EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography ( ERCP ) pancreatitis ( PEP ) among high‐risk individuals: A post‐hoc analysis of a randomized controlled trial data

Mahesh K Goenka, Venkata S Akshintala iD, Ayesha Kamal, Furqan A Bhullar, Nikhil Bush, Vijay Kumar, Madhurima Chakraborty, Merve Gurakar, Sundeep Lakhtakia, Rupjyoti Talukdar, Guru Trikudanathan, Mouen A Khashab und 5 weitere

Journal of Digestive Diseases · 2023

DOI: 10.1111/1751-2980.13208 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Mahesh K Goenka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Gastrosciences and Liver, Apollo Gleneagles Hospital, Kolkata, India. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: American Society for Gastrointestinal Endoscopy (2014 Endoscopic Research Award) to Dr. Vikesh Singh and Dr. Venkata Akshintala.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To systematically evaluate the patient and procedural risk factors for post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) among patients receiving rectal indomethacin.

Methods

Data from a randomized controlled trial (RCT) of high‐risk patients undergoing ERCP who received rectal indomethacin with or without topical epinephrine was evaluated. PEP was defined based on the consensus criteria. Pancreatic stenting was excluded to avoid confounding results with the role of epinephrine spray. Multivariable logistic regression analysis was used to identify patient and procedural risk factors for PEP.

Results

Among 960 patients enrolled in the RCT, the PEP incidence was 6.4%. An increased risk of PEP was seen with age 2 guidewire passes into the pancreatic duct (PD) (OR 2.84, 95% CI 1.43–5.64), and pancreatic brush cytology (OR 6.37, 95% CI 1.10–36.90), whereas a decreased risk of PEP was seen with contrast‐ over guidewire‐assisted cannulation (OR 0.14, 95% CI 0.02–0.99) and the use of lactated Ringer's (LR) over other fluid types (OR 0.52, 95% CI 0.27–0.98). There was a significant trend between the number of guidewire passes into the PD and PEP risk ( P = 0.002).

Conclusions

More than two guidewire passes into the PD and pancreatic brush cytology increased while the use of LR decreased the risk of PEP among high‐risk patients receiving rectal indomethacin. Pancreatic stent placement and/or LR should be considered in patients with >2 guidewire passes into the PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangiopancreatography, Endoscopic RetrogradePancreatitisFemaleHumansMiddle AgedCatheterizationEpinephrineIndomethacinPancreatic DuctsRisk FactorsMaleAdult

Stichwörter der Autor:innen

endoscopic retrograde cholangiopancreatographyguidewirepancreatitis

Substanzen

EpinephrineIndomethacin

Autor:innen und Institutionen

  • Institute of Gastrosciences and Liver, Apollo Gleneagles Hospital, Kolkata, India.
  • Division of Gastroenterology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
  • Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
  • Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Gastroenterology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

ORCID-Profile: Venkata S Akshintala

Förderung

  • American Society for Gastrointestinal Endoscopy (2014 Endoscopic Research Award) to Dr. Vikesh Singh and Dr. Venkata Akshintala

Zitieren

APA

Goenka, M. K., Akshintala, V. S., Kamal, A., Bhullar, F. A., Bush, N., Kumar, V., Chakraborty, M., Gurakar, M., Lakhtakia, S., Talukdar, R., Trikudanathan, G., Khashab, M. A., Kalloo, A. N., Reddy, D. N., Sinha, S. K., Singh, V. K., & Kochhar, R. (2023). Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography ( ERCP ) pancreatitis ( PEP ) among high‐risk individuals: A post‐hoc analysis of a randomized controlled trial data. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13208

Vancouver

Goenka MK, Akshintala VS, Kamal A, Bhullar FA, Bush N, Kumar V, et al. Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography ( ERCP ) pancreatitis ( PEP ) among high‐risk individuals: A post‐hoc analysis of a randomized controlled trial data. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13208

BibTeX
@article{Goenka2023,
  author = {Goenka, Mahesh K and Akshintala, Venkata S and Kamal, Ayesha and Bhullar, Furqan A and Bush, Nikhil and Kumar, Vijay and Chakraborty, Madhurima and Gurakar, Merve and Lakhtakia, Sundeep and Talukdar, Rupjyoti and Trikudanathan, Guru and Khashab, Mouen A and Kalloo, Anthony N and Reddy, D Nageshwar and Sinha, Saroj K and Singh, Vikesh K and Kochhar, Rakesh},
  title = {Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography ( ERCP ) pancreatitis ( PEP ) among high‐risk individuals: A post‐hoc analysis of a randomized controlled trial data},
  journal = {Journal of Digestive Diseases},
  year = {2023},
  doi = {10.1111/1751-2980.13208}
}
Kostenlos starten →